期刊
SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE
卷 18, 期 1, 页码 -出版社
AOSIS
DOI: 10.4102/sajhivmed.v18i1.776
关键词
-
资金
- Southern African HIV Clinicians Society
- SA HIV Clinicians Society
- Gilead Sciences
- AbbVie
- Janssen
- BD
- Gilead
- Merck
- Cipla
- Mylan
- Aspen
These guidelines are intended as an update to those published in the Southern African Journal of HIV Medicine in 2014 and the update on when to initiate antiretroviral therapy in 2015. Since the release of the previous guidelines, the scale-up of antiretroviral therapy (ART) in southern Africa has continued. New antiretroviral drugs have become available with improved efficacy, safety and robustness. The guidelines are intended for countries in the southern African region, which vary between lower and middle income.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据